Health Technology/clinical-trials

Machine Learning vs Logistic Regression for Predicting Prolonged Mechanical Ventilation in Acute Hypoxemic Respiratory Failure: Findings from 1,241-Patient PANDORA Cohort

247 Health News Editorial

·

26 July 2026

·

4 min read

·clinical-trials

A completed Spanish study of 1,241 ICU patients has applied machine learning algorithms to predict prolonged mechanical ventilation (≥7 days) in acute hypoxemic respiratory failure using only 48-hour clinical data. The PANDORA cohort analysis compares ML approaches against logistic regression to identify the minimum variable set needed for accurate early prediction — with significant implications for ICU resource planning and weaning protocol initiation.

Originally reported by ClinicalTrials.gov

References

  1. 1.Villar, J. (2025). Prediction of duration of mechanical ventilation in patients with acute hypoxemic respiratory failure using machine learning approaches. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06815523
  2. 2.Zilberberg, M. D., & Shorr, A. F. (2008). Prolonged acute mechanical ventilation and hospital bed utilization in 2020 in the United States: Implications for budgets, plant and personnel planning. BMC Health Services Research, 8, 242. https://doi.org/10.1186/1472-6963-8-242
  3. 3.Rajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022). AI in health and medicine. Nature Medicine, 28(1), 31–38. https://doi.org/10.1038/s41591-021-01614-0
  4. 4.Medam, S., Zieleskiewicz, L., Duclos, G., Baumstarck, K., Pochard, F., Loundou, A., Antonini, F., & Leone, M. (2018). Risk factors for death in patients with COVID-19 and acute respiratory distress syndrome: A descriptive study. Medicine, 97(27), e13828. https://doi.org/10.1097/MD.0000000000013828
  5. 5.Bellani, G., Laffey, J. G., Pham, T., Fan, E., Brochard, L., Esteban, A., Gattinoni, L., van Haren, F., Larsson, A., McAuley, D. F., Ranieri, M., Rubenfeld, G., Thompson, B. T., Wrigge, H., Slutsky, A. S., & Pesenti, A. (2016). Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA, 315(8), 788–800. https://doi.org/10.1001/jama.2016.0291
  6. 6.Villar, J., Ferrando, C., Martínez, D., Ambrós, A., Muñoz, T., Soler, J. A., Aguilar, G., Alba, F., González-Higueras, E., Conesa, L. A., Martín-Rodríguez, C., Díaz-Domínguez, F. J., Serna-Grande, P., Rivas, R., Ferreres, J., Belda, J., Capilla, L., Tallet, A., Añón, J. M., & Fernández, R. L. (2020). Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial. The Lancet Respiratory Medicine, 8(3), 267–276. https://doi.org/10.1016/S2213-2600(19)30417-5
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service